Study to Assess the Safety and Tolerability of PT010, PT009 and PT003 in Subjects With Moderate to Very Severe Chronic Obstructive Pulmonary Disease
Clinical trial NCT02536508 · COMPLETED
Trial details
- NCT number
- NCT02536508
- Sponsor
- Pearl Therapeutics, Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2015-08-10
- Primary completion
- 2017-09-12
- Enrollment
- 627
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.